CenterPoint Energy stock: Houston’s load boom comes with a $66.7B bill

CNP was up 0.1% at $36.84, but that move has no verified company-specific explanation. No Reddit mentions and no fresh headlines in the last day do not establish why the share price ticked higher. CenterPoint’s Q2 earnings release, dated July 28, 2026, was the nearest material company update—not a new announcement today.

That release reported Q2 2026 non-GAAP EPS of $0.40, versus $0.29 in Q2 2025, and reiterated 2026 non-GAAP EPS guidance of $1.89-$1.91. GAAP diluted EPS was $0.37, so the adjusted result is not interchangeable with reported GAAP earnings. CenterPoint attributed $0.10 per share of year-over-year favorability to growth and regulatory recovery; increased interest expense and weather and usage each detracted $0.01 per share. (Q2 2026 earnings release)

The business update was more consequential than the day’s quiet tape: CenterPoint raised its planned 2026-2035 capital investment by $1.2 billion to $66.7 billion. It cited Houston large-load demand and refined estimates for the Downtown Houston Revitalization project. The company said this increase would not raise its current equity-financing guide. That is management’s financing statement, not proof that future funding costs or dilution are immaterial.

CenterPoint said it submitted over 17 gigawatts of large-load projects through ERCOT’s Batch Zero process, of which approximately 14 gigawatts are expected to be eligible as base load or studied load. Management said approximately 14 gigawatts of eligible base or studied load were projected by 2031—more than 65% of Houston Electric’s current 21-gigawatt peak demand. Those are company-reported pipeline figures and expectations, not a tally of customers already taking power. (Q2 2026 earnings release)

The distinction matters financially. A utility generally has to build or upgrade infrastructure before it can serve new demand; earnings depend on whether projects secure the necessary approvals, are completed, and enter the rate base with costs recoverable from customers. CenterPoint’s release itself flags ERCOT approval, the allocation and timing of load, funding, execution, and timely recovery as risks. Its forecast that new connections could reduce Houston residential and commercial delivery charges by at least $5 billion over the next decade is a company projection—not realized savings or evidence that all proposed load will arrive.

CNP’s reported fundamentals show why capital productivity deserves as much attention as demand. FY2025 metrics show $9.36 billion of revenue, a 22.6% operating margin and 5.3% ROIC, alongside $20.5 billion of net debt. TTM free cash flow is negative $2.7 billion and the FCF yield is -11.0%. Heavy investment can be normal for a utility, but negative free cash flow means the growth plan must rely on external funding and regulated recovery rather than cash left after capital expenditure.

There is no prior SageNoodle fair value to carry forward, so this is a preliminary earnings-multiple estimate, not a full regulated-asset valuation. The base case applies an assumed 19x multiple to the midpoint of management’s 2026 non-GAAP EPS guidance, $1.90: $1.90 × 19 = $36.10 per share. At the supplied $36.84 price, the shares are about 2.1% above that estimate—within the range for a fairly valued verdict, not a meaningful margin of safety.

The assumed multiple is an analyst input, not company guidance. The estimate also inherits the limitations of adjusted EPS: CenterPoint says its non-GAAP measure excludes items including ZENS-related changes in value, merger and divestiture impacts, and certain TEEEF impacts, and warns that guidance depends on assumptions such as customer growth, capital recovery, financing and regulatory proceedings. Its 22.6x TTM P/E uses reported trailing earnings and is not directly comparable to the forward adjusted-EPS multiple used here. The valuation question is whether the load and capital program can support durable earnings growth after funding and regulatory costs—not whether a large project queue looks impressive on a slide.

The thesis improves if the ERCOT process converts eligible projects into approved, energized load and CenterPoint recovers the associated investment on schedule, while keeping financing needs within its stated plan. It weakens if approvals or connections slip, construction costs rise, recovery lags, or interest expense and equity issuance absorb the growth. The company’s 2026 guidance is reiterated, not raised; the expanded capital plan therefore increases the opportunity and the execution burden without changing near-term earnings guidance.

The next useful evidence is not another headline about demand, but company disclosures showing approvals, customer connections, capital spending, financing and regulatory recovery. Until then, the 0.1% move remains a market observation without a verified company-specific explanation.